about
RP-HPLC method with electrochemical detection for the determination of metoclopramide in serum and its use in pharmacokinetic studies.Modern chromatographic and electrophoretic measurements of antidepressants and their metabolites in biofluids.Column Selection for Biomedical Analysis Supported by Column Classification Based on Four Test Parameters.Chemometric evaluation of the column classification system during the pharmaceutical analysis of lamotrigine and its related substances.Determination of Bendamustine in Human Plasma and Urine by LC-FL Methods: Application in a Drug MonitoringStrategies for the Assessment of Metabolic Profiles of Steroid Hormones in View of Diagnostics and Drug Monitoring: Analytical Problems and Challenges.Capillary electromigration techniques as tools for assessing the status of vitamins A, C and E in patients with cystic fibrosis.Determination of urinary biogenic amines' biomarker profile in neuroblastoma and pheochromocytoma patients by MEKC method with preceding dispersive liquid-liquid microextraction.Development of the HPLC Method for Simultaneous Determination of Lidocaine Hydrochloride and Tribenoside Along with Their Impurities Supported by the QSRR Approach.Micellar electrokinetic chromatography for the determination of cortisol in urine samples in view of biomedical studies.Classification of LC columns based on the QSRR method and selectivity toward moclobemide and its metabolites.Chemometric optimization of derivatization reactions prior to gas chromatography-mass spectrometry analysis.Comparative evaluation between capillary electrophoresis and high-performance liquid chromatography for the analysis of florfenicol in plasma.Comparison of core-shell and totally porous ultra high performance liquid chromatographic stationary phases based on their selectivity towards alfuzosin compounds.Simultaneous determination of urinary cortisol, cortisone and corticosterone in parachutists, depressed patients and healthy controls in view of biomedical and pharmacokinetic studies.Gel electrophoretic separation of proteins from cultured neuroendocrine tumor cell lines.Sensitive quantification of chosen drugs by reversed-phase chromatography with electrochemical detection at a glassy carbon electrode.Assessment of column selection systems using Partial Least Squares.Comparison of Three Extraction Approaches for the Isolation of Neurotransmitters from Rat Brain Samples.Biomedical evaluation of cortisol, cortisone, and corticosterone along with testosterone and epitestosterone applying micellar electrokinetic chromatography.Chemometric analysis for optimizing derivatization in gas chromatography-based proceduresRecent Trends in the Quantification of Biogenic Amines in Biofluids as Biomarkers of Various Disorders: A Review.Chemometric evaluation of urinary steroid hormone levels as potential biomarkers of neuroendocrine tumors.Comparison of HPLC and CE methods for the determination of cetirizine dihydrochloride in human plasma samplesThe comparison of two column classification systems during the chromatographic analysis of steroidsOptimization of LC method for the determination of testosterone and epitestosterone in urine samples in view of biomedical studies and anti-doping research studiesEvaluation of a column classification method using the separation of alfuzosin from its related substancesCyclodextrin-modified MEKC method for quantification of selected acidic metabolites of catecholamines in the presence of various biogenic amines. Application to diagnosis of neuroblastomaDynamic double coating, electrophoretic method with indirect detection for the simultaneous quantification of mono- and divalent cations in various water samplesIonic liquids as signal amplifiers for the simultaneous extraction of several neurotransmitters determined by micellar electrokinetic chromatographyOptimization of LC method for the quantification of doxorubicin in plasma and urine samples in view of pharmacokinetic, biomedical and drug monitoring therapy studiesEvaluation of various approaches to the isolation of steroid hormones from urine samples prior to FASS-MEKC analysisPoultry Farms as a Potential Source of Environmental Pollution by PharmaceuticalsSimultaneous electrokinetic and hydrodynamic injection and sequential stacking featuring sweeping for signal amplification following MEKC during the analysis of rapamycin (sirolimus) in serum samplesApplication of SPME supported by ionic liquids for the determination of biogenic amines by MEKC in clinical practiceDetermination of twenty pharmaceutical contaminants in soil using ultrasound-assisted extraction with gas chromatography-mass spectrometric detectionThe Influence of Ionic Liquids on the Effectiveness of Analytical Methods Used in the Monitoring of Human and Veterinary Pharmaceuticals in Biological and Environmental Samples-Trends and PerspectivesCombination of field amplified sample injection and hydrophobic interaction electrokinetic chromatography (FASI-HIEKC) as a signal amplification method for the determination of selected macrocyclic antibiotics
P50
Q30780963-203E0C48-6392-4075-8686-66502F18FB11Q33759563-CB893403-4E37-4858-AAF4-5B2D77D21416Q36512707-02FB1883-2F9C-4840-8D4B-0A75BBCF057AQ37018748-ACF1BFB4-8FEB-40CE-B4AE-2EA4BF5881CEQ37059359-474D7336-5165-4207-A26E-9A59876749EAQ38823726-FD58FEC5-09AC-48E5-9317-7C58B998A4F5Q39126021-8294CC87-F727-4744-BEC8-7B56DC16C2B0Q39281126-08A0CE10-88AF-4CAD-9C0B-5AD6CFE9E8ECQ42211298-9A9972CF-469D-4EDD-9078-86CB9D4BA49EQ43005727-EC5396D3-D0D5-464F-88A6-2EDE8AD0F8E7Q43746342-E7508352-042E-4EE8-B98A-17AC87841819Q45265667-856EEA8D-81E7-4428-9522-50DBD6AC6443Q46637835-B32A7579-BD5C-42BD-B0B0-AA669C4EA20AQ47598467-9F842483-6CD7-4036-95D9-733800142883Q48907424-735A7529-DA86-4D40-8FA3-FBFAF817B756Q50220730-CD5F1C45-B966-428A-A78A-33B46B1A66D3Q51196076-B88ED8C4-E8B5-47B5-9F1A-D5548A11276CQ51690042-8CCBCA5B-9C9F-47F7-BBD7-EC4080D60D9DQ55642180-E681510C-B774-4CE2-9C9A-3C714530B432Q55645884-8E2266D7-63A0-436C-B663-BEFE8F42D323Q60480722-28527D15-342B-4D4A-BD7F-1447387A587CQ64889147-8F0490BC-AEBD-40C0-8C4E-C4DF3CBF9B77Q64939562-9711FB7C-5B2F-4F77-B872-3C5E992FA47EQ80180196-5CCEA698-5441-4D9E-A2CC-842691041F7AQ82264268-F428B51B-58A8-4013-A531-DB4713546292Q82832445-862785F5-F89C-43F5-BB55-C49C09594C1FQ83396081-7A794A56-1B4F-411A-B5F3-F5FDCD9B2629Q86249202-79D8B9D5-374A-44B2-9E39-2EDC009D1B43Q88550133-DAB82B43-C183-4F07-8464-3A004947722BQ88762167-42323B62-E859-4972-81F8-159F77A378F6Q89219151-9919DCE2-D1D9-4E40-B0CB-8DAC3500E6A5Q89554838-B1CE2816-7001-49A3-B8DC-0B445A170A2AQ89920712-9974D715-D9FA-4258-BA0C-784BC9F2455CQ90342661-94B3530E-59A2-4AAF-B8E7-8E1834FAA0FBQ92190445-8865E1D9-D8A6-4D86-9932-D664BFC33EB4Q92464623-C8B0C7C8-6561-40CA-86C5-F15AC943A702Q92637285-1400C46F-7136-4E0F-BED3-629C1BD4CA7FQ93346301-AE54A8A0-476D-4B33-A30F-43F5678AD550
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alina Plenis
@ast
Alina Plenis
@en
Alina Plenis
@es
Alina Plenis
@nl
type
label
Alina Plenis
@ast
Alina Plenis
@en
Alina Plenis
@es
Alina Plenis
@nl
prefLabel
Alina Plenis
@ast
Alina Plenis
@en
Alina Plenis
@es
Alina Plenis
@nl
P106
P31
P496
0000-0002-0507-2770